TriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ:MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL 2025 1 1246578.X, covering methods of synthesizing RNA molecules. The new patent covers TriLink's full suite of CleanCap® capping analogs, including its latest M6 analog. CleanCap technology is a critical component of the production of synthetic mRNA as drug develop
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology
- ZeroStack Announces Results of 2026 Annual and Special Meeting of Shareholders, Provides Phatebo Purchase Orders Update and Announces Closing of Previously Announced Cryptocurrency Financing
Dallas, Texas--(Newsfile Corp. - July 20, 2026) - ZeroStack Corp. (NASDAQ:ZSTK) ("ZeroStack" or the "Company"), the first Nasdaq-listed, AI-focused asset management company, held its 2026 Annual and Special Meeting of Shareholders (the "Meeting"). The final voting results of the proposals submitted to a vote of the Company's shareholders at the Meeting are as follows: Proposal 1: Election of five directors to the board of directors of the Company (the "Board") to hold office until the Company's 2027 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified. If Proposal 7 is approved, the Board will be staggered as described in the proxy statement/pros
- AGNC Investment Corp. Announces Second Quarter 2026 Financial Results
BETHESDA, Md., July 20, 2026 /PRNewswire/ -- AGNC Investment Corp. ("AGNC" or the "Company") (NASDAQ:AGNC) today announced financial results for the quarter ended June 30, 2026. SECOND QUARTER 2026 FINANCIAL HIGHLIGHTS $0.52 comprehensive income per common share, comprised of:$0.52 net income per common share$(0.01) other comprehensive loss ("OCI") per common share on investments marked-to-market through OCI$0.40 net spread and dollar roll income per common share1Excludes less than $(0.01) per common share of estimated "catch-up" premium amortization cost due to change in projected constant prepayment rate ("CPR") estimates$8.58 tangible net book value per common share as of June 30, 2026In
- Ross Expands Footprint With 47 New Stores
DUBLIN, Calif., July 20, 2026 /PRNewswire/ -- Ross Stores, Inc. (NASDAQ:ROST) announced the grand opening of 47 new stores nationwide during June and July, including 35 Ross Dress for Less® ("Ross") and 12 dd's DISCOUNTS® locations across 15 states and territories. With these new openings, the Company is on track to open approximately 110 stores this year. "Each new opening allows us to deliver compelling value to even more customers while creating new jobs and making a positive impact in the local communities," said Richard Lietz, Executive Vice President, Property Development. "Building on the strong new store performance in 2025 and the Spring openings this year, we are excited to grow Ro
- Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
Arcturus Therapeutics Holdings Inc. ((the "Company", "Arcturus", NASDAQ:ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will present at the following investor conference in Boston, Massachusetts: Canaccord Genuity 46th Annual Growth Conference (Fireside Chat) Tuesday, August 11, 2026 (12:00 p.m. ET) Webcast link can be found under Investor Relations/Events section of Arcturus’ website. About Arcturus Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is a messenger RNA medicines company focused on the development of liver and
- Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
– Freenome common stock expected to begin trading on the Nasdaq Capital Market under the ticker symbol "FRNM" on July 21, 2026 – – Gross proceeds to Freenome totaled more than $300 million through a PIPE, led by Perceptive Advisors and RA Capital, and funds held by Perceptive Capital Solutions Corp’s trust account – – Capital will support Freenome’s cancer screening portfolio, AI/ML-enabled multiomics platform and commercial infrastructure - BRISBANE, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Freenome Holdings, Inc. ("Freenome") (NASDAQ:FRNM), an early cancer detection company developing blood-based screening tests, today announced the closing of its previously announced business combin
- Definium Therapeutics Announces New Employee Inducement Grants
Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 30,330 common shares of the Company (the "Options") with effective grant dates of July 20, 2026. The Options have an exercise price equal to the closing price of Definium’s common shares on the date of the grants, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and t
- Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 34 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ("the Company" or "Zealand Pharma") (NASDAQ:ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, has received information on transactions in Zealand Pharma's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions. Please see the attached file(s). # # # About Zealand Pharm
- Ranger Energy Services, Inc. Announces Date for Second Quarter 2026 Earnings Conference Call
Ranger Energy Services, Inc. (NYSE:RNGR) (the "Company") will report second quarter financial and operating results after the market closes for trading on Monday, July 27, 2026. Following the announcement, the Company’s management will host an earnings conference call the morning of Tuesday, July 28, 2026 at 10:00 a.m. Eastern time (9:00 a.m. Central time). Interested parties are invited to join the call by dialing 1-833-255-2829, or 1-412-902-6710 for international calls, (request to join the Ranger Energy Services call) or via the Company’s website at www.rangerenergy.com. A replay of the conference call will be available following the call and can be accessed from www.rangerenergy.com.
- Hanover Bancorp, Inc. Appoints Kevin O’Connor President
MINEOLA, N.Y., July 20, 2026 (GLOBE NEWSWIRE) -- Hanover Bancorp, Inc. (NASDAQ:HNVR) ("the Company") and Hanover Community Bank (the "Bank"), announced that they have named Kevin O’Connor to the position of President of the Company and the Bank effective July 27, 2026. In this role, Mr. O’Connor will fuel expansion and regional growth throughout the Long Island market by strengthening client relationships and unlocking new business opportunities and strategic initiatives in this underserved market. "Kevin is a highly respected banking leader whose deep market knowledge, relationship-driven approach and longstanding commitment to Long Island will be an outstanding addition to Hanover Bank,
- Gentherm Medical Receives FDA Clearance for ThermAffyx™ Patient Safety System
NOVI, Mich., July 20, 2026 (GLOBE NEWSWIRE) -- Gentherm, a global market leader of innovative thermal management and pneumatic comfort technologies, announced today it received FDA 510(k) clearance for its patented ThermAffyx™ Patient Safety System. This Class II medical device combines active patient warming, securement and pressure reduction in a single platform designed for the more than 3 million robotic-assisted surgical procedures performed annually worldwide. Product trials at healthcare facilities are scheduled to begin in August, with revenue generation expected to commence in Q3 2026. Historically, surgical teams have pieced together separate solutions to address warming and sec
- Tegus Cuts Conversation Intelligence Spend 50% by Consolidating Its Tech Stack with ZoomInfo
The investment-research platform moved conversation intelligence onto a vendor it already used, cutting that spend by 50% while preserving three years of recorded calls. ZoomInfo (NASDAQ:GTM), the all-in-one AI GTM platform, has reported that Tegus, an investment-research platform that investors rely on to inform their decisions, cut its conversation-intelligence spending by 50% compared with its previous vendor after consolidating that work onto ZoomInfo, according to the company. Tegus redirected the savings into sales incentives and went on to exceed its targets for the next 2 quarters. Tegus combines expert insights, company filings, key performance indicators, and financial data in
- Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units
Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually Products are distributed across Albania and recommended by doctors and healthcare professionals, supporting broad consumer accessExpansion builds on the partnership launched in April 2025 and reflects Sky Premium Life's continued global growth CHICAGO, July 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced an expansion of its partnership with Pharma Cell for the distribution of its Sky
- I&M PLANS FOR ROCKPORT'S NEXT CHAPTER AS A FULL-FLEDGED ENERGY HUB TO MEET CUSTOMERS' NEEDS
Project will not impact I&M's plans to reduce rates for customersFORT WAYNE, Ind., July 20, 2026 /PRNewswire/ -- Indiana Michigan Power (I&M) is taking the next step to ensure its customers have reliable power for decades to come, while positioning Rockport, Indiana, for long-term economic success. I&M has requested approval from the Indiana Utility Regulatory Commission (IURC) to build a 1,520 megawatt (MW) natural gas combined cycle generation facility at its Rockport site, to increase its generation capacity and meet the projected energy demand across Indiana. The project does not impact I&M's plans to reduce rates for customers. The investment is already contemplated within I&M's upcomin
- How Seismic Scaled AI-Driven Prospecting Across Its Sales Team with ZoomInfo
The global leader in sales enablement made its top sellers' outbound results repeatable across the whole go-to-market team by layering AI-assisted prospecting on ZoomInfo data. ZoomInfo (NASDAQ:GTM), the all-in-one AI GTM platform, has reported that Seismic, the global leader in sales enablement, scaled AI-assisted outbound prospecting across its go-to-market team on ZoomInfo, and in its own user surveys attributed 39% of active pipeline to opportunities identified or influenced by signals from ZoomInfo, according to the company. Seismic runs a well-developed outbound model, where business development representatives and outside sales reps generate the majority of its pipeline, and accu
- Travel + Leisure Co. Completes $300 Million Term Securitization
Travel + Leisure Co. (NYSE:TNL) announced today it completed a term securitization transaction involving the issuance of $300 million in principal amount of asset-backed notes with an overall weighted average coupon of 5.52%. The advance rate for this transaction was 98.00%. "The ABS market has long been an important funding source for our business. This transaction provides efficient access to capital with attractive economics and reflects the continued investor demand for our receivables platform," said Erik Hoag, Chief Financial Officer of Travel + Leisure Co. "Maintaining consistent access to capital provides the financial flexibility necessary to invest in our business while preservi
- Miller Expands Deltaweld® and Auto Deltaweld® Lineup With New 600-Amp System
Platform expands to meet growing power demands across more applications Miller Electric Mfg. LLC, a leading worldwide manufacturer of Miller® brand arc welding equipment, announces the launch of the new Deltaweld 600 and Auto Deltaweld 600, extending the proven Deltaweld platform to 600 amps. Built for operations that need more power when the job calls for it, Deltaweld 600 and Auto Deltaweld 600 enable an operation to weld with higher amperage for longer periods while continuing to use a system they already know. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260720899612/en/Photo of the Deltaweld 600 on white background "The
- Infleqtion CEO Matt Kinsella Provides Testimony for House Committee on Natural Resources
Kinsella to Discuss Legislation that Would Modernize Critical Minerals Mapping through Quantum Technologies Infleqtion (NYSE:INFQ), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, today announced that its CEO, Matthew Kinsella, will testify before the U.S. House of Representatives Committee on Natural Resources to discuss the Quantum-Enhanced Critical Minerals Mapping Act of 2026. The committee will hold a legislative hearing Tuesday, July 21, at 10:15 a.m. EDT. Viewers can stream live on the YouTube feed, and additional information can be found on the hearing page. The Quantum-Enhanced Critical Minerals Mapping Act of 2026 represents a sig
- Experienced Advisor with $160 Million in Assets Joins Ameriprise Financial to Expand Capabilities and Grow Client Impact
Kevin King says joining Ameriprise showed him "the grass truly is greener" Private wealth advisor Kevin King JD, CFP®, AAMS®, CPWA®, recently joined the independent channel of Ameriprise Financial, Inc. (NYSE:AMP) from Edward Jones in Idaho Falls, Idaho, where he managed approximately $160 million in client assets. King wasn’t initially looking to make a move but says he was compelled to reconsider after evaluating Ameriprise’s capabilities. "I’m consistently focused on doing what’s best for my clients," he said. "Once I saw what Ameriprise has to offer and how they continually invest in improving the client experience, it became an easy decision to move so I can deliver an even higher
- Why The Busch School of Business Standardized Its Sales Training on ZoomInfo
The business school of The Catholic University of America built ZoomInfo into its Sales Practicum course to close the gap between conceptual coursework and the hands-on skills new sales reps need. ZoomInfo (NASDAQ:GTM), the all-in-one AI GTM platform, has reported that The Busch School of Business at The Catholic University of America built ZoomInfo into its Sales Practicum course, and 72.5% of the prospects its students generated were judged outreach-worthy by corporate partners, up from 58% the previous semester without it, according to the school. Founded in 2013, the Busch School runs a sales program built to prepare students to compete virtuously in the world of sales. It had a pro